These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38095280)

  • 1. The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer.
    Johnstone MS; McSorley ST; McMillan DC; Horgan PG; Mansouri D
    Colorectal Dis; 2024 Jan; 26(1):81-94. PubMed ID: 38095280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
    Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
    Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Co-morbidity, Screen-Detection and Outcome in Patients Undergoing Resection for Colorectal Cancer.
    Johnstone MS; McMillan DC; Horgan PG; Mansouri D
    World J Surg; 2021 Jul; 45(7):2251-2260. PubMed ID: 33774690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
    Qi Q; Geng Y; Sun M; Wang P; Chen Z
    Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
    Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
    Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
    Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Systemic Inflammation Markers in the Survival of Patients with Complicated Colorectal Cancer, Operated in Emergency.
    Constantin GB; Firescu D; Voicu D; Ștefănescu B; Serban RMC; Panaitescu E; Bîrlă R; Constantinoiu S
    Chirurgia (Bucur); 2020; 115(1):39-49. PubMed ID: 32155398
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer.
    Xiao Z; Wang X; Chen X; Zhou J; Zhu H; Zhang J; Deng W
    Front Oncol; 2023; 13():1064343. PubMed ID: 37064153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.
    Jin M; Kim M; Jeon MJ; Kim EY; Shin DY; Kim BH; Kim WB; Shong YK; Lim DJ; Kim WG
    Endocrine; 2023 Aug; 81(2):298-305. PubMed ID: 36928602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL).
    Kriplani A; Pandit S; Chawla A; de la Rosette JJMCH; Laguna P; Jayadeva Reddy S; Somani BK
    Urolithiasis; 2022 Jun; 50(3):341-348. PubMed ID: 35246692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
    Karan C; Yaren A; Demirel BC; Dogan T; Ozdemir M; Demiray AG; Taskoylu BY; Degirmencioglu S; Dogu G; Ozhan N; Cakiroglu U; Celikyurek A
    Cancer Diagn Progn; 2023; 3(6):706-715. PubMed ID: 37927800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
    Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
    BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
    Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
    Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
    Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.